Welcome to LookChem.com Sign In|Join Free

CAS

  • or

937593-04-9

Post Buying Request

937593-04-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

937593-04-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 937593-04-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,7,5,9 and 3 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 937593-04:
(8*9)+(7*3)+(6*7)+(5*5)+(4*9)+(3*3)+(2*0)+(1*4)=209
209 % 10 = 9
So 937593-04-9 is a valid CAS Registry Number.

937593-04-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(3-bromophenyl)-2-(3-hydroxyphenyl)ethane-1,2-dione

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:937593-04-9 SDS

937593-04-9Downstream Products

937593-04-9Relevant articles and documents

Design and synthesis of cyclic acylguanidines as BACE1 inhibitors

Liu, Jia-Kuo,Gu, Wei,Cheng, Xiao-Rui,Cheng, Jun-Ping,Zhou, Wen-Xia,Nie, Ai-Hua

, p. 1327 - 1330 (2015/12/31)

Based on the lead compound 1 reported in literature, a series of novel BACE1 inhibitors were designed and synthesized, among which compound 11 exhibited a 14-fold improvement in potency over the lead compound 1. This represents a good lead for the discovery of more promising BACE1 inhibitors for the potential treatment of AD.

NEW COMPOUNDS

-

Page/Page column 166, (2008/06/13)

This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 937593-04-9